Enoxaparin Sodium is a low molecular weight heparin (LMWH) obtained by alkaline depolymerization of heparin benzyl ester. As an active pharmaceutical ingredient (API), it is a complex mixture of sulfated glycosaminoglycan chains with potent anticoagulant and antithrombotic properties.

Used in the manufacture of finished injectable drugs for the:

• Prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
• Management of acute coronary syndromes (e.g., unstable angina, non-Q-wave myocardial infarction).
• Prevention of thrombus formation during hemodialysis.

Packaging: Supplied in securely sealed, temperature-controlled containers (e.g., double polyethylene bags inside fiber drums) to ensure stability during transit and storage.